* AxoGen Inc AXGN.OQ reported a quarterly adjusted loss
of 20
cents per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 15
cents per share.
* Revenue fell 0.1% to $31.01 million from a year ago;
analysts
expected $30.79 million.
* AxoGen Inc's reported EPS for the quarter was a loss of 27
cents.
* The mean earnings estimate of analysts had fallen by
about 43.7%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* AxoGen Inc shares had risen by 4.0% this quarter and
lost 11.8%
so far this year.
* The company reported a quarterly loss of $11.48 million.
* Wall Street's median 12-month price target for AxoGen Inc
is
$20.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated May 5 at 09:04 p.m. All
figures in US dollars unless otherwise stated